FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

17345311000001102: OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60223801000001115 OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60223901000001114 OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Is a Oxycodone 20mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has AMP OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start